ELI LILLY & Co SEC Filing (Aug 17, 2026)

Eli Lilly & Co. has filed a Form 144 with the SEC on August 17, 2026, indicating a proposed sale of 6,500 shares of common stock with an aggregate market value of $7,638,150. The securities were acquired on February 10, 2025, as a stock bonus from the issuer. This filing provides details about the transaction and the filer's representation regarding material adverse information.